Clinicians & researchers on record
Expert Conversations
A curated compendium of full-length interview transcripts and edited highlights with clinicians and researchers who have worked directly with ibogaine and noribogaine.
Each entry is built to make context visible: who is speaking, when they spoke, the affiliation or study context named in the record, and the limits of what an interview can establish.
A legible record
Conversation needs a provenance trail.
Entries identify the interview date, source, speaker bio, affiliation where stated, and whether the discussion concerns a study, a clinic context, a regulatory question, or clinical practice. The goal is not to turn a quotation into a conclusion; it is to preserve the conditions under which a statement was made.
This compendium sits alongside the broader Ibogaine Interviews resource, while the site’s research landscape offers a separate place to follow the evidence categories that interviewees may reference.
How entries are read
From a spoken claim to its cited context.
Ibogaine and noribogaine conversations often move across pharmacology, safety practice, regulation, and follow-up. To keep those subjects distinct, each record can point readers to the underlying material rather than leaving a statement detached from its source.
- Locate the statement. Timestamped clips or pull-quotes identify the precise passage, including discussion of safety, dosing ranges, cardiac risk, or follow-up outcomes.
- State the evidence level. Notes mark whether a speaker is describing an observation, a published result, or a question that remains unresolved in the available record.
- Check the reference. Where interviewees cite a paper or agency position, the entry links back to primary literature or an official statement for direct review.
Interpretation without hype
Claims remain claims until the record supports more.
Interview material can reveal how a clinician or researcher frames a question, but it does not substitute for trial design, regulatory review, or individualized medical advice. The entries make room for uncertainty, disagreement, and the difference between a cited result and a speaker’s interpretation of it.
Safety in context
Discussion of cardiac risk is annotated carefully. The FDA warning on serious ibogaine-associated risks is a relevant regulatory reference when conversations address monitoring, contraindications, or acute risk.
“A timestamp shows what was said; an annotation shows what kind of statement it was.”
Terms that matter
Tags do not erase nuance, but they make records easier to compare. Readers can distinguish ibogaine from noribogaine’s metabolite context, and separate pharmacology discussion from clinical practice or jurisdictional policy.
“A short clip should remain connected to the full conversation and its stated setting.”
Contradictions noted
When a statement conflicts with published evidence, the record flags the tension rather than smoothing it away. Broader safety questions can also be read alongside the safety and screening framework, where the focus remains on careful interpretation rather than treatment direction.
“Observation and controlled evidence are labeled differently because they answer different questions.”
Practical reading notes
Questions the compendium keeps in view.
Records are designed for people interested in ibogaine interviews who want a clear route from a memorable remark to the context and source behind it.
What makes an interview entry usable?
A usable entry identifies the speaker’s context, the date and source of the conversation, the specific statement being annotated, and whether the statement describes direct observation or controlled-trial evidence.
How are safety statements handled?
Safety statements are retained in context and accompanied, where possible, by the primary literature or regulatory material cited in the conversation. For instance, discussion of a drug’s regulatory status can be checked against the DEA’s ibogaine fact sheet rather than inferred from a clip alone.
Does a speaker’s observation establish efficacy?
No. An interview may document an observation, but it is not treated as controlled-trial evidence or as medical guidance. That distinction is central to the independent information approach described on the Ibogaine Interviews mission page.
Why include the full-length source?
Full context helps readers hear qualifications, limitations, and follow-up questions that may be absent from a short quotation. It also supports direct review of the primary literature and official statements referenced by interviewees.
Keep the context attached
Use interviews as a starting point for closer reading.
For people comparing interview claims with questions about treatment settings, the independent overview of ibogaine treatment centers in Mexico may help distinguish location-specific discussion from the evidence and safety questions addressed in a recorded conversation.
Explore the resource approach